Rheumatology leaders urge HHS to adopt drug policy principles that protect patient access

(American College of Rheumatology) In response to the Trump Administration's American Patients First drug pricing blueprint, the American College of Rheumatology — which represents more than 7,700 rheumatologists and rheumatology health professionals in the US 0- today issued a set of policy principles that rheumatology leaders urge federal officials to adopt as they consider drug policy changes affecting the health care of chronically ill Americans.